Logo image of CNVI.CA

CONAVI MEDICAL CORP (CNVI.CA) Stock Price, Forecast & Analysis

Canada - TSX Venture Exchange - TSX-V:CNVI - CA2059531020 - Common Stock

0.54 CAD
0 (0%)
Last: 11/27/2025, 7:00:00 PM

CNVI.CA Key Statistics, Chart & Performance

Key Statistics
Market Cap41.45M
Revenue(TTM)8.76M
Net Income(TTM)-16.22M
Shares76.75M
Float42.97M
52 Week High0.83
52 Week Low0.35
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.85
PEN/A
Fwd PEN/A
Earnings (Next)12-18 2025-12-18
IPO2008-04-28
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


CNVI.CA short term performance overview.The bars show the price performance of CNVI.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 20 30

CNVI.CA long term performance overview.The bars show the price performance of CNVI.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years -1 -2 -3 -4 -5

The current stock price of CNVI.CA is 0.54 CAD. In the past month the price decreased by -6.9%. In the past year, price decreased by -5.26%.

CONAVI MEDICAL CORP / CNVI Daily stock chart

CNVI.CA Latest News, Press Relases and Analysis

CNVI.CA Competitors/Peers

The largest stocks on the Canadian markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
PRN.CA PROFOUND MEDICAL CORP N/A 274.13M
MIR.CA MEDMIRA INC N/A 56.87M
TLT.CA THERALASE TECHNOLOGIES INC N/A 38.41M
ASG.CA AURORA SPINE CORP N/A 21.24M
PINK.CA PERIMETER MEDICAL IMAGING AI N/A 21.16M
NSCI.CA NANALYSIS SCIENTIFIC CORP N/A 19.68M
MDX.CA MEDX HEALTH CORP N/A 18.04M
VPT.CA VENTRIPOINT DIAGNOSTICS LTD N/A 15.09M
THRM.CA THERMA BRIGHT INC N/A 2.84M
IVC-H.CA INTERCONNECT VENTURES CORP N/A 1.07M
VER-H.CA VERISANTE TECHNOLOGY INC N/A 439.40K
IDL.CA IMAGING DYNAMICS CO LTD N/A 413.20K

About CNVI.CA

Company Profile

CNVI logo image Conavi Medical Corp. engages in the designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The company is headquartered in Toronto, Ontario and currently employs 4 full-time employees. The company went IPO on 2008-04-28. The firm is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The Novasight Hybrid System is intended for intravascular imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional procedures. Its Novasight Hybrid System combines both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. Hybrid IVUS and OCT imaging provides additional information over single modality imaging in complex lesions. The versatility of hybrid imaging is useful for a variety of complex percutaneous coronary interventions (PCIs), including situations where the customer may want to image large ostial lesions with IVUS but also use OCT for diseased distal lesions and/or stent assessment.

Company Info

CONAVI MEDICAL CORP

76 Berkeley Street

TORONTO ONTARIO CA

Employees: 4

CNVI Company Website

CNVI Investor Relations

Phone: 14165487522

CONAVI MEDICAL CORP / CNVI.CA FAQ

What does CNVI do?

Conavi Medical Corp. engages in the designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The company is headquartered in Toronto, Ontario and currently employs 4 full-time employees. The company went IPO on 2008-04-28. The firm is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The Novasight Hybrid System is intended for intravascular imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional procedures. Its Novasight Hybrid System combines both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. Hybrid IVUS and OCT imaging provides additional information over single modality imaging in complex lesions. The versatility of hybrid imaging is useful for a variety of complex percutaneous coronary interventions (PCIs), including situations where the customer may want to image large ostial lesions with IVUS but also use OCT for diseased distal lesions and/or stent assessment.


What is the current price of CNVI stock?

The current stock price of CNVI.CA is 0.54 CAD.


Does CONAVI MEDICAL CORP pay dividends?

CNVI.CA does not pay a dividend.


What is the ChartMill rating of CONAVI MEDICAL CORP stock?

CNVI.CA has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Where is CONAVI MEDICAL CORP (CNVI.CA) stock traded?

CNVI.CA stock is listed on the TSX Venture Exchange exchange.


How many employees does CONAVI MEDICAL CORP have?

CONAVI MEDICAL CORP (CNVI.CA) currently has 4 employees.


CNVI.CA Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to CNVI.CA. When comparing the yearly performance of all stocks, CNVI.CA turns out to be only a medium performer in the overall market: it outperformed 53.9% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

CNVI.CA Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to CNVI.CA. CNVI.CA may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CNVI.CA Financial Highlights

Over the last trailing twelve months CNVI.CA reported a non-GAAP Earnings per Share(EPS) of -0.85. The EPS decreased by -128.21% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -140.24%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%84.51%
Sales Q2Q%N/A
EPS 1Y (TTM)-128.21%
Revenue 1Y (TTM)821.58%

CNVI.CA Forecast & Estimates

5 analysts have analysed CNVI.CA and the average price target is 1.02 CAD. This implies a price increase of 88.89% is expected in the next year compared to the current price of 0.54.


Analysts
Analysts80
Price Target1.02 (88.89%)
EPS Next YN/A
Revenue Next YearN/A

CNVI.CA Ownership

Ownership
Inst Owners0.33%
Ins Owners0.22%
Short Float %N/A
Short RatioN/A